repotrectinib
Showing 1 - 4 of 4
Trial (Repotrectinib)
Available
- Repotrectinib
- (no location specified)
Jun 30, 2023
Advanced Cancer, Metastatic Solid Tumor Trial in New York (Repotrectinib, Irinotecan and temozolomide)
Recruiting
- Advanced Cancer
- Metastatic Solid Tumor
- Repotrectinib
- Irinotecan and temozolomide
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Dec 1, 2022
NSCLC Trial in Worldwide (Repotrectinib, Crizotinib)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Repotrectinib
- Crizotinib
-
Augusta, Georgia
- +40 more
Nov 29, 2023